Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.

Kilbourne AM, Post EP, Bauer MS, Zeber JE, Copeland LA, Good CB, Pincus HA.

J Affect Disord. 2007 Sep;102(1-3):145-51. Epub 2007 Feb 5.

PMID:
17276514
2.

Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care.

Galbally M, Snellen M, Walker S, Permezel M.

Aust N Z J Psychiatry. 2010 Feb;44(2):99-108. doi: 10.3109/00048670903487217. Review.

PMID:
20113298
3.

Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.

Bowden CL.

J Clin Psychiatry. 2005;66 Suppl 3:12-9. Review.

4.

Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.

Ketter TA, Nasrallah HA, Fagiolini A.

Psychopharmacol Bull. 2006;39(1):120-46. Review.

PMID:
17065977
5.

Algorithms for the pharmacotherapy of bipolar disorder.

Motohashi N.

Psychiatry Clin Neurosci. 1999 Oct;53 Suppl:S41-4. Review.

6.

Medical risk in patients with bipolar disorder and schizophrenia.

Newcomer JW.

J Clin Psychiatry. 2006;67 Suppl 9:25-30; discussion 36-42. Review.

7.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
8.
9.

Pharmacotherapeutic strategies for pediatric bipolar disorder.

Madaan V, Chang KD.

Expert Opin Pharmacother. 2007 Aug;8(12):1801-19. Review.

PMID:
17696785
10.

Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring.

Musenga A, Saracino MA, Sani G, Raggi MA.

Curr Med Chem. 2009;16(12):1463-81. Review.

PMID:
19355900
11.

[Are mood stabilizers beneficial in the treatment of schizophrenia?].

Berle JØ, Spigset O.

Tidsskr Nor Laegeforen. 2005 Jun 30;125(13):1809-12. Review. Norwegian.

12.
13.

Treatment-refractory bipolar disorder: classification to aid in clinical management.

Gajwani P.

Expert Opin Pharmacother. 2009 Aug;10(12):1907-15. doi: 10.1517/14656560903064170. Review.

PMID:
19606936
14.

Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.

Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D.

Bipolar Disord. 2007 Sep;9(6):551-60. Review.

PMID:
17845269
15.

Update on the treatment and management of schizophrenia and bipolar disorder.

Buckley PF.

CNS Spectr. 2008 Feb;13(2 Suppl 1):1-10; quiz 11-2. Review.

PMID:
18227747
16.

Management of bipolar disorder during pregnancy and the postpartum period.

Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L.

Am J Psychiatry. 2004 Apr;161(4):608-20. Review.

PMID:
15056503
17.

Side effects as influencers of treatment outcome.

Sharif Z.

J Clin Psychiatry. 2008;69 Suppl 3:38-43. Review.

18.

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.

Yatham LN, Kennedy SH, O'Donovan C, Parikh S, MacQueen G, McIntyre R, Sharma V, Silverstone P, Alda M, Baruch P, Beaulieu S, Daigneault A, Milev R, Young LT, Ravindran A, Schaffer A, Connolly M, Gorman CP; Canadian Network for Mood and Anxiety Treatments.

Bipolar Disord. 2005;7 Suppl 3:5-69. Review.

PMID:
15952957
19.

Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder?

Haymond J, Ensom MH.

Ther Drug Monit. 2010 Feb;32(1):19-29. doi: 10.1097/FTD.0b013e3181c13a30. Review.

PMID:
19901867
20.

Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.

Misra M, Papakostas GI, Klibanski A.

J Clin Psychiatry. 2004 Dec;65(12):1607-18; quiz 1590, 1760-1. Review.

PMID:
15641865

Supplemental Content

Support Center